Tech Company Financing Transactions
Courtagen Life Sciences Funding Round
On 8/16/2010, Courtagen Life Sciences raised $7 million in funding from private investors.
Transaction Overview
Company Name
Announced On
8/16/2010
Transaction Type
Venture Equity
Amount
$7,008,402
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12 Gill St. 3700
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Website
Email Address
Overview
Courtagen Life Sciences is the premier genetic testing company, specializing in neurological & metabolic disorders including mitochondrial disease, epilepsy & seizure disorders, and developmental delay / intellectual disability / autism spectrum disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian McKernan
Chief Financial Officer
Jeff Forward
Chief Scientific Officer
Kevin McKernan
President
Brendan McKernan
VP - Human Resources
Elizabeth Holland
Browse more venture capital transactions:
Prev: 8/16/2010: Cardlytics venture capital transaction
Next: 8/16/2010: 24M Technologies venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs